CPT is a real estate investment trust (REIT) that invests in and manages shopping mall properties.
As an owner of regional malls, its core identity is focused on generating income from long-term retail tenant leases and property appreciation.
Updated: February 27, 2026, 16:00 EST
CPT shows steady, low-volatility performance, recently gaining 6.25% over three months but still trading well below its 52-week high. Positioned in the lower half of its yearly range, the stock appears to be consolidating rather than overbought, suggesting room for potential appreciation if momentum continues.
The company exhibits strong profitability with net income margins improving to nearly 40%, supported by healthy gross margins above 62%. However, weak interest coverage and low operational efficiency metrics like ROE (3.6%) indicate some financial constraints. Efficient working capital management is a positive, but leverage and cash flow coverage need monitoring.
CPT trades at a premium TTM P/E of 28.87, though the forward P/E of 19.02 and a PEG ratio of 0.43 signal expected earnings growth ahead. The high EV/EBITDA of 45.81 raises questions, but without industry peers for comparison, itβs difficult to assess relative valuation conclusively.
With a beta of 0.83, CPT is less volatile than the market, though its 22% maximum drawdown last year underscores downside risk. The absence of short interest reduces squeeze risk, but investors should watch liquidity and company-specific operational factors.
Consider Buying with Caution. CPT offers a blend of solid profitability, modest technical rebound potential, and attractive growth expectations per its PEG ratio. However, premium absolute valuation and below-par operational efficiency advise a measured approach. Suitable for investors seeking stable, growth-oriented exposure but comfortable with moderate leverage and valuation risks.
Based on the provided analysis, here is a 12-month outlook for CPT:
Over the next 12 months, the primary catalyst for CPT is its attractive earnings growth trajectory, as signaled by its low PEG ratio, which could drive price appreciation from its current consolidating technical position. The stock's low beta also offers a potential haven during broader market volatility. Key risks include its premium absolute valuation metrics, particularly the high EV/EBITDA, and financial constraints indicated by weak interest coverage and low operational efficiency (ROE). While analyst targets are unavailable, the combination of expected earnings growth and current valuation suggests a cautious target price range in the mid-to-high $110s, contingent on the company demonstrating improved operational efficiency and stable cash flow.
Most Wall Street analysts are optimistic about Camden Property Trust's 12-month outlook, with consensus target around $108.34, indicating expected upside potential.
Overall, CPT has investment potential but also faces challenges. Here are key factors to weigh before investing.
CPT has delivered modest positive returns but remains significantly below its 52-week high despite recent gains.
Over the past three months, the stock has risen 6.25% and has modestly outperformed the market by 0.62%, though its 1-month performance of 1.21% has been more subdued, reflecting its low beta volatility profile relative to broader market movements. This suggests stable, albeit unspectacular, short-term performance.
Currently trading at $110.24, CPT sits in the lower half of its 52-week range ($97.17 - $126.55), indicating it is not overbought; given the substantial distance from its high and a maximum drawdown of -22.27% over the past year, the stock appears to be in a relatively undervalued or consolidating position rather than an oversold one.
| Period | CPT Return | S&P 500 |
|---|---|---|
| 1m | +1.0% | -1.4% |
| 3m | +3.0% | +4.1% |
| 6m | -0.1% | +7.5% |
| 1y | -12.7% | +15.4% |
| ytd | -1.7% | +0.4% |
Revenue & Profitability CPT demonstrates solid profitability with improving margins, as the net income ratio increased from 27.5% in Q3 to 39.9% in Q4. Quarterly revenue showed slight moderation sequentially, but a gross profit ratio above 62% reflects healthy pricing power. Strong net profitability indicates effective cost control despite a modest revenue decline.
Financial Health The company maintains moderate leverage with a debt-to-equity ratio of 0.89 and a debt ratio of 43%, though the low interest coverage of 2.3 warrants monitoring. Cash flow coverage ratios are relatively weak at 0.05, suggesting limited capacity for debt service from operating cash flows. The negative cash conversion cycle highlights efficient working capital management.
Operational Efficiency Operational metrics show modest efficiency with an asset turnover of 0.043 and an ROE of 3.6%, indicating suboptimal utilization of assets and equity. The low capital turnover is offset by high receivables turnover, pointing to effective collections. Overall efficiency appears constrained despite solid cash flow generation per share.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardValuation Level: CPT's TTM PE ratio of 28.87 indicates a premium valuation, signaling the stock may be overvalued based on current earnings. However, the significantly lower forward PE of 19.02 suggests that analysts anticipate substantial earnings growth in the coming year. Supporting this outlook, the PEG ratio of 0.43 is well below 1.0, which traditionally points to potential undervaluation when future growth is factored into the price.
Peer Comparison: A definitive peer comparison cannot be provided as industry average data is unavailable. The elevated EV/EBITDA ratio of 45.81 appears high on an absolute basis, which typically suggests a rich valuation, but this assessment lacks context without industry benchmarks. Further analysis would require comparable industry multiples to determine CPT's relative standing.
The stock exhibits moderate volatility risk, with a beta of 0.83 indicating it is generally less volatile than the broader market. However, the one-year maximum drawdown of -22.27% highlights a significant potential for capital loss during market downturns, representing a notable risk for investors.
The risk profile is somewhat tempered by the absence of short interest, which eliminates the threat of a short squeeze. Primary remaining considerations would center on overall market liquidity and potential event-driven risks specific to the company's operations and sector.
Neutral to Bearish. While CPT trades below its 52-week high and has a compelling forward PEG ratio suggesting growth potential, the consensus "sell" analyst rating and premium TTM P/E of 28.87 are significant headwinds. The stock may appeal to patient, income-focused investors attracted by its strong dividend reputation, but the negative institutional sentiment and mixed performance create near-term uncertainty.
Based on the data provided, CPT appears undervalued when factoring in expected earnings growth. While the current PE ratio of 28.87 seems high on an absolute basis, the more telling metrics are the forward PE of 19.02 and the PEG ratio of 0.43. The PEG ratio, being significantly below 1.0, strongly indicates that the stock's price is not keeping pace with its anticipated earnings growth. This potential undervaluation is further supported by the company's demonstrated strong profitability with a net income ratio nearing 40%, suggesting the market may be underestimating its future earnings power.
Based on the provided information, here are the key risks of holding CPT stock, ordered by importance:
1. Limited Financial Flexibility: The company's low interest coverage ratio of 2.3 and weak cash flow coverage ratio of 0.05 indicate a constrained ability to service its existing debt, especially in a rising interest rate environment. 2. Suboptimal Operational Efficiency: The low asset turnover of 0.043 and Return on Equity (ROE) of 3.6% suggest the company is not generating strong returns from its asset base, posing a risk to long-term earnings growth. 3. Market Downturn Vulnerability: Despite a beta below 1, the stock's maximum drawdown of -22.27% demonstrates a significant potential for capital loss during broader market declines.
Based on the provided analysis, here is my CPT stock forecast for 2026:
My 2026 forecast sets a base case target price in the low-to-mid $120s and a bull case target approaching the $140s, driven by the continued execution of its earnings growth story and improved operational efficiency (ROE). The key growth catalysts are its low PEG ratio signaling attractive earnings growth potential and its low beta offering defensive appeal during market volatility. This outlook assumes the company can strengthen its weak interest coverage and cash flow coverage ratios while maintaining its high profit margins and effective collections. This projection carries significant uncertainty due to the absence of analyst consensus and is highly contingent on management's ability to address financial constraints without compromising profitability.